IBEX (IBEX) CEO sells 6,000 common shares at $28.4588 average

Rhea-AI Filing Summary

IBEX Ltd director and Chief Executive Officer Robert Thomas Dechant reported an open-market sale of 6,000 Common Shares. The shares were sold at a weighted average price of $28.4588 per share in multiple trades. After this transaction, he directly owns 275,406 Common Shares.

The sale price reflects a weighted average of individual trades executed between $28.25 and $29.02 per share, and detailed trade breakdowns are available upon request as noted in the filing footnote.

Insider Trade Summary

Net Seller: 6,000 shares ($170,753)

Net Sell 1 txn

Insider Dechant Robert Thomas

Role Chief Executive Officer

Sold 6,000 shs ($171K)

Type	Security	Shares	Price	Value
Sale	Common Shares	6,000	$28.4588	$171K

Holdings After Transaction: Common Shares — 275,406 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dechant Robert Thomas

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	02/23/2026		S		6,000	D	$28.4588(1)	275,406	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $28.25 to $29.02; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did IBEX (IBEX) CEO Robert Dechant report in this Form 4?

Robert Thomas Dechant reported selling 6,000 IBEX Common Shares in an open-market transaction. The sale used a weighted average price of $28.4588 per share, and he continues to hold 275,406 Common Shares directly after the transaction.

At what price were the IBEX shares sold in this insider transaction?

The reported transaction used a weighted average sale price of $28.4588 per share. According to the footnote, individual trades occurred at prices ranging from $28.25 to $29.02, with the average reported as the official transaction price in the filing.

How many IBEX shares does the CEO own after this Form 4 sale?

Following the reported sale, Robert Thomas Dechant directly owns 275,406 IBEX Common Shares. This figure reflects his direct holdings after disposing of 6,000 shares in the open market, as disclosed in the non-derivative transaction section.

What type of transaction did the IBEX CEO execute in this filing?

The filing shows an open-market sale of IBEX Common Shares, coded as “S” for sale. It is a non-derivative transaction, meaning it involved common stock directly rather than options, warrants, or other derivative securities.

What does the Form 4 footnote say about the IBEX share sale prices?

The footnote explains the sale was executed in multiple trades between $28.25 and $29.02 per share. The $28.4588 figure is the weighted average, and full trade-by-trade pricing details are available from the reporting person upon request.